BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 14703541)

  • 1. The quality of randomised controlled trials may be better than assumed.
    del Giglio A; Costa LJ
    BMJ; 2004 Jan; 328(7430):24-5. PubMed ID: 14703541
    [No Abstract]   [Full Text] [Related]  

  • 2. Reported quality of randomized controlled trials of physiotherapy interventions has improved over time.
    Moseley AM; Herbert RD; Maher CG; Sherrington C; Elkins MR
    J Clin Epidemiol; 2011 Jun; 64(6):594-601. PubMed ID: 21144705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of randomised controlled trials: quality of research may be worse than it appears.
    Vlassov VV
    BMJ; 2004 Jan; 328(7434):286. PubMed ID: 14751906
    [No Abstract]   [Full Text] [Related]  

  • 4. Quality of randomised controlled trials: quality of trial methods is not good in all disciplines.
    Handoll HH
    BMJ; 2004 Jan; 328(7434):286. PubMed ID: 14751907
    [No Abstract]   [Full Text] [Related]  

  • 5. Examining heterogeneity in phase II trial designs may improve success in phase III.
    Tuma RS
    J Natl Cancer Inst; 2008 Feb; 100(3):164-6. PubMed ID: 18230788
    [No Abstract]   [Full Text] [Related]  

  • 6. The Children's Oncology Group routinely applies "lack of efficacy" interim monitoring to its randomized clinical trials.
    Anderson JR; Krailo M
    Am J Bioeth; 2011 Mar; 11(3):18-9. PubMed ID: 21400379
    [No Abstract]   [Full Text] [Related]  

  • 7. Methodological quality and reporting of ethical requirements in phase III cancer trials.
    Tuech JJ; Pessaux P; Moutel G; Thoma V; Schraub S; Herve C
    J Med Ethics; 2005 May; 31(5):251-5. PubMed ID: 15863678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bad reporting does not mean bad methods for randomised trials: observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group.
    Soares HP; Daniels S; Kumar A; Clarke M; Scott C; Swann S; Djulbegovic B;
    BMJ; 2004 Jan; 328(7430):22-4. PubMed ID: 14703540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized phase II trials: misleading and unreliable.
    Stewart DJ
    J Clin Oncol; 2010 Nov; 28(31):e649-50; author reply e651-3. PubMed ID: 20855829
    [No Abstract]   [Full Text] [Related]  

  • 10. Quality of randomised controlled trials: caution is important.
    Brewer NJ
    BMJ; 2004 Jan; 328(7434):286-7. PubMed ID: 14751905
    [No Abstract]   [Full Text] [Related]  

  • 11. Improving the reporting quality of randomised controlled trials in surgery.
    Carney S
    Int J Surg; 2007 Dec; 5(6):376. PubMed ID: 18063433
    [No Abstract]   [Full Text] [Related]  

  • 12. Improving the quality of reports of randomised controlled trials: the CONSORT statement.
    Otwombe KN; Ogutu B
    East Afr Med J; 2002 Jul; 79(7):394-6. PubMed ID: 12638837
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation of single arm versus randomised phase 2 oncology trial characteristics with phase 3 outcome.
    Monzon JG; Hay AE; McDonald GT; Pater JL; Meyer RM; Chen E; Chen BE; Dancey JE
    Eur J Cancer; 2015 Nov; 51(17):2501-7. PubMed ID: 26338195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why did the study fail?
    Dellapasqua S; Castiglione-Gertsch M
    Eur J Cancer; 2005 Dec; 41(18):2784-6. PubMed ID: 16253501
    [No Abstract]   [Full Text] [Related]  

  • 15. Consort 2010 statement on randomised controlled trials.
    Murphy JF
    Ir Med J; 2010 May; 103(5):132. PubMed ID: 20666080
    [No Abstract]   [Full Text] [Related]  

  • 16. Early stopping for benefit in National Cancer Institute-sponsored randomized Phase III trials: the system is working.
    Sargent D
    J Clin Oncol; 2009 Apr; 27(10):1543-4. PubMed ID: 19237627
    [No Abstract]   [Full Text] [Related]  

  • 17. Quality control and quality assurance in HIV prevention research: model from a multisite HIV prevention trial. NIMH Multisite HIV Prevention Trial.
    AIDS; 1997 Dec; 11 Suppl 2():S49-53. PubMed ID: 9475711
    [No Abstract]   [Full Text] [Related]  

  • 18. On the efficiency of targeted clinical trials.
    Maitournam A; Simon R
    Stat Med; 2005 Feb; 24(3):329-39. PubMed ID: 15551403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trend in methodological quality of randomised clinical trials in low back pain.
    Koes BW; Malmivaara A; van Tulder MW
    Best Pract Res Clin Rheumatol; 2005 Aug; 19(4):529-39. PubMed ID: 15949774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses.
    Moher D; Cook DJ; Jadad AR; Tugwell P; Moher M; Jones A; Pham B; Klassen TP
    Health Technol Assess; 1999; 3(12):i-iv, 1-98. PubMed ID: 10374081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.